Development of a Novel Method to Study in Vivo Fatty Acid Metabolism Using Stable Isotope Labeled Fatty Acids in Humans
NCT02312492 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6
Last updated 2019-04-18
Summary
Specific Aim 1: To compare the metabolic fate (transport, conversion and oxidation) of labeled 18:0 (13C18:0) and its metabolic product 18:1 (13C18:1) in the fed state after habituation to diets enriched in the corresponding fatty acid.
Hypothesis: In the fed state, the metabolic fate of 13C18:0 compared to 13C18:1 will be characterized by similar transport, higher conversion, and similar oxidation rates..
Conditions
Interventions
- OTHER
-
Oleic Diet
The 18:1 (oleic) diet will contain 55%E carbohydrate, 15%E protein, 30%E fat, 100 mg cholesterol/1000 kcal and 15 g fiber/1000 kcal. The vegetable oils and/or fats (henceforth collectively referred to as experimental oils) that will be used to formulate the diets were selected not only take into account the fatty acid of interest but also the fatty acid displaced within the context of an unchanged total fat content. This was accomplished by formulating a diet containing 10%E fat and then adding the experimental oils (oleic) to 30%E total fat by incorporating them into various food items intended for consumption throughout the day. The actual food items comprising the 3 diets will be similar, only differing in the experimental oils.
- OTHER
-
Palmitic Diet
The 16:0 (palmitic) diet will contain 55%E carbohydrate, 15%E protein, 30%E fat, 100 mg cholesterol/1000 kcal and 15 g fiber/1000 kcal. The vegetable oils and/or fats (henceforth collectively referred to as experimental oils) that will be used to formulate the diets were selected not only take into account the fatty acid of interest but also the fatty acid displaced within the context of an unchanged total fat content. This was accomplished by formulating a diet containing 10%E fat and then adding the experimental oils (palmitic) to 30%E total fat by incorporating them into various food items intended for consumption throughout the day. The actual food items comprising the 3 diets will be similar, only differing in the experimental oils.
- OTHER
-
Stearic Diet
The 18:0 diet (stearic) will contain 55%E carbohydrate, 15%E protein, 30%E fat, 100 mg cholesterol/1000 kcal and 15 g fiber/1000 kcal. The vegetable oils and/or fats (henceforth collectively referred to as experimental oils) that will be used to formulate the diets were selected not only take into account the fatty acid of interest but also the fatty acid displaced within the context of an unchanged total fat content. This was accomplished by formulating a diet containing 10%E fat and then adding the experimental oil (stearic) to 30%E total fat by incorporating them into various food items intended for consumption throughout the day. The actual food items comprising the 3 diets will be similar, only differing in the experimental oils.
Sponsors & Collaborators
-
Tufts University
lead OTHER
Principal Investigators
-
Alice H Lichtenstein, D.Sc. · Tufts University/HNRCA
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 50 Years
- Max Age
- 85 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-01-31
- Primary Completion
- 2016-06-30
- Completion
- 2018-12-31
Countries
- United States
Study Locations
More Related Trials
-
Nutritional Oleic Acid Modulation of adIpose Cholesterol Metabolism in Patients Living With Obesity
NCT07027033 ·Status: RECRUITING ·Phase: NA
-
Dietary Fat, Eicosanoids and Breast Cancer Risk
NCT01824498 ·Status: COMPLETED ·Phase: NA
-
Exploratory Study of the Effects of Omega-3-acid Ethyl Esters on the Lipid and Lipoprotein Profile in the Blood
NCT02839902 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Plant Sterols Esterified to Fish Oil Fatty Acids on Plasma Lipid Levels
NCT00441480 ·Status: COMPLETED ·Phase: PHASE4
-
A Human In Vivo Feeding Study Of The Blood Monocyte Response To Dietary Lipid Intake
NCT02101346 ·Status: TERMINATED ·Phase: NA
-
Explore Effects of Dietary Fish Oil in Human Skin
NCT03122912 ·Status: TERMINATED ·Phase: PHASE1
-
Palmitoleic Isomer Study
NCT02311790 ·Status: COMPLETED ·Phase: NA
-
Influence of of a Lipid Emulsion on Inflammatory Response and Hepatic Function
NCT00600912 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Fish Oils With Dairy or Plant Based Lipids on Mitochondrial and Physical, and Cognitive Function, in Elderly Humans
NCT04194983 ·Status: TERMINATED ·Phase: NA
-
Transcriptomics of Mononuclear Cells and Inflammatory Status of Obese Patients Treated With Omega-3 Fatty Acids
NCT05219890 ·Status: WITHDRAWN ·Phase: NA
-
Effects of Omega-3 Fatty Acids on Markers of Inflammation
NCT01129050 ·Status: COMPLETED ·Phase: NA
-
Dietary Omega-7 Palmitoleic Acid-Rich Oil on Lipoprotein Metabolism and Satiety in Adults
NCT03372733 ·Status: RECRUITING ·Phase: PHASE2
-
Effect of Conjugated Linoleic Acid Supplement on Body Composition
NCT00347373 ·Status: COMPLETED ·Phase: NA
-
Differential Metabolism of Dietary Fatty Acids
NCT00059254 ·Status: COMPLETED ·Phase: NA
-
Effects of Dietary Fatty Acids on Octadecanoid Production and Biological Actions in Obesity-induced Inflammation
NCT03583281 ·Status: COMPLETED ·Phase: NA
-
Metabolic Effects of Linoleic Acid-Rich Oil Compared to a Blend Oil in Adults With Insulin Resistance
NCT07287514 ·Status: RECRUITING ·Phase: NA
-
Use of Conjugated Linoleic Acid as a Nutraceutical for Weight Loss in Humans
NCT01047280 ·Status: COMPLETED ·Phase: PHASE1
-
Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood
NCT04496154 ·Status: COMPLETED ·Phase: NA
-
Fish Oils and Adipose Inflammation Reduction
NCT02010359 ·Status: COMPLETED ·Phase: PHASE4
-
Is Omega-3 Fatty Acid Red Blood Cell (RBC) Saturation Product Dependent?
NCT01091714 ·Status: COMPLETED ·Phase: PHASE4
-
Exploratory Study of the Effect of Omega-3-acid Ethyl Esters (TAK-085) on Vascular Endothelial Function in Patients With Hyperlipidemia by Flow Mediated Dilation
NCT02824432 ·Status: COMPLETED ·Phase: PHASE4
-
Vascular and Lipid Effects of Omega-3 Fatty Acids in People With Moderately Elevated Triglycerides
NCT00504309 ·Status: COMPLETED ·Phase: NA
-
Effects of N-3 Intake on Lipid Profile, Biochemical and Inflammatory Markers in Subjects with Obesity
NCT04901052 ·Status: COMPLETED ·Phase: NA
-
Different Lipid Emulsions in Acute Lung Injury Patients
NCT01814956 ·Status: TERMINATED ·Phase: PHASE4
-
Variability in Human Fatty Acids Profiles Based on Blood Fractions and Metabolic Conditions
NCT06731400 ·Status: NOT_YET_RECRUITING ·Phase: NA